172@29@16@22!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals

BSE Live

Oct 23, 16:00
783.05 0.60 (0.08%)
Volume
AVERAGE VOLUME
5-Day
121,839
10-Day
118,855
30-Day
158,747
143,789
  • Prev. Close

    782.45

  • Open Price

    782.45

  • Bid Price (Qty.)

    780.05 (10)

  • Offer Price (Qty.)

    783.05 (132)

NSE Live

Oct 23, 15:59
782.80 0.60 (0.08%)
Volume
AVERAGE VOLUME
5-Day
4,330,534
10-Day
3,655,702
30-Day
4,152,894
2,221,295
  • Prev. Close

    782.20

  • Open Price

    780.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    782.80 (1689)

Financials

2019 2018 2017 2016 2015
Cash Flow of Aurobindo Pharma (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 2,377.70 1,964.62 2,342.94 2,178.57 2,147.84  
Net CashFlow From Operating Activities 2,161.73 529.89 922.40 2,457.20 1,185.18  
Net Cash Used In Investing Activities -921.57 -1,297.36 -990.60 -1,542.05 -1,390.11  
Net Cash Used From Financing Activities -1,252.39 599.40 439.69 -1,328.99 514.97  
Foreign Exchange Gains / Losses 2.97 -3.18 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents -9.26 -171.25 371.49 -413.84 310.04  
Cash And Cash Equivalents Begin of Year 68.70 239.95 -131.54 283.90 -26.14  
Cash And Cash Equivalents End Of Year 59.44 68.70 239.95 -129.94 283.90  
Source : Dion Global Solutions Limited